Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 3 Results

  1. 1
    334981

    WHO prequalification of male circumcision devices. Public report. Product: PrePex. Number: PQMC 0001-001-00. Version 1.0.

    World Health Organization [WHO]

    [Geneva, Switzerland], WHO, 2013 May. [15] p. (PQMC 0001-001-00)

    PrePex with product codes DW0201, DW0202, DW0203, DW0204 and DW0205, manufactured by Circ MedTech Limited, CE-marked regulatory version, was accepted for the WHO list of prequalified male circumcision devices and was listed on 31 May 2013. PrePex is a single use, disposable device; indicated for circumcision of adult men, defined as circumferential excision of the foreskin or prepuce at or near the level of coronal sulcus, with minimal amount of preputial skin remaining. The device should not be used if the package has been compromised. Use by trained personnel only. All device components should not be reused at the risk of cross contamination. The device is intended for adults only and is not applicable for males under the age of 18. The device should be used only in settings where suitable surgical facilities and skills are available within a short time frame (6-12 hours) in order to manage potentially serious complications resulting from device displacements. Device displacement when wearing the device, may lead to the risk of adverse events. Informing the patient of safe behavior when wearing the device is critical. PrePex includes the following items: 1. Placement Ring 2. Elastic Ring 3. Inner Ring 4. Verification Thread Accessories: The PrePex Sizing Plate (PSP) is intended for single use for selecting an appropriate device size. The use of PrePex requires additional tools and materials which are not supplied with PrePex. For Placement: examination gloves, antiseptic solution, skin marker, gauze, 5% anesthetic cream and nurse utility scissors. For Removal: examination gloves, antiseptic solution, sterile harvey wire scissors, sterile forceps, sterile spatula, sterile scalpel, 2 wound dressings, nurse utility scissors and a cutter. Storage: The test kit should be stored at -10 to 55 °C. Shelf-life: 3 years.
    Add to my documents.
  2. 2
    181701

    It takes 2: partnering with men in reproductive and sexual health. UNFPA programme advisory note.

    Cohen SI; Burger M; Dairo AE; Mbugua W

    New York, New York, United Nations Population Fund [UNFPA], 2003. 46, 6 p. (UNFPA Programme Advisory Note)

    This document is intended to help UNFPA country staff plan national programmes, develop strategies and projects, review progress made, and assess the soundness of their strategies. It illustrates how one can increase men’s involvement in reproductive health issues through research, advocacy, behaviour change communication and education, policy dialogues and well-tailored and innovative reproductive health services. It starts by defining partnering with men and providing a rationale for this approach from the standpoint of the International Conference on Population and Development (ICPD). A framework for selecting essential elements of such a programme is then described. Examples are provided of ways in which UNFPA has supported a partnering approach, followed by a summary of lessons learned. A matrix of sample outputs and their indicators provides options for defining and measuring results. Additional resources are also provided for information on gender, masculinities, adolescent boys, education, services, working with special populations, and research on partnering with men. (excerpt)
    Add to my documents.
  3. 3
    077662

    WHO laboratory manual for the examination of human semen and semen-cervical mucus interaction. 2nd ed.

    World Health Organization [WHO]. Special Programme of Research, Development and Research Training in Human Reproduction

    Cambridge, England, Cambridge University Press, 1987. [7], 67 p.

    The WHO Special Programme of Research, Development and Research Training in Human Reproduction has revised its manual designed to standardize procedures for the examination of human semen. This revised manual, for instance, describes a simplified method for screening the morphology of cellular elements other than spermatozoa; the previous method now appears in the section on optional procedures. WHO has also included methods to determine the presence of spermatozoa antibodies. The manual has guidelines on measurement of biochemical components of seminal plasma to evaluate the secretory function of accessory glands (e.g., fructose indicates secretory function of the seminal vesicles). Even though these biochemical tests may not mark a man's fertility, they demonstrate the functional state of these glands. Besides, someday they may even help assess the possible effects of xenobiotic factors and of disease. Some researchers believe adenosine triphosphate levels are linked to spermatozoal function and that the zona free hamster oocyte test can determine the ability of human spermatozoa to join with the oocyte; so WHO has listed protocols for these 2 tests. The manual also has protocols to assess the ability of spermatozoa to penetrate cervical mucus in vitro: the microscopic method and the capillary tube test. WHO believes that determining this ability is important when evaluating the fertility of a couple. The Standard Procedures section on collection and examination of human semen considers appearance, volume, consistency, pH, motility, preparation and grading, agglutination, sperm viability, sperm count, and testing for antibody-coating of spermatozoa. The section on sperm cervical mucus interaction examines volume, consistency, ferning, spinnbarkeit, cellularity, pH, and in vivo and in vitro tests. It hopes that researchers will adapt the standard procedures presented in this manual to improve quality control between laboratories and allow aggregation of data from several sources for analysis.
    Add to my documents.